Creatine Monohydrate: Clinical Dose Ranges and What the Research Describes

What creatine monohydrate is

Creatine is a naturally occurring compound synthesised in the liver, kidneys, and pancreas from the amino acids arginine, glycine, and methionine. It is also obtained through diet — primarily from meat and fish. The body stores creatine mainly in skeletal muscle, where it participates in rapid ATP regeneration during short, intense efforts.

Creatine monohydrate is the most studied form of supplemental creatine. It has a well-established safety profile across more than three decades of research, and no clinically meaningful benefit of alternative forms (creatine ethyl ester, buffered creatine, creatine HCl) over monohydrate has been demonstrated in well-controlled trials [Jäger et al. 2011].

The clinical dose range

What research shows for strength and power output

Creatine monohydrate has more randomised controlled trial evidence than almost any other sports supplement. The mechanistic basis is well understood: by increasing phosphocreatine availability in muscle, creatine allows faster regeneration of ATP during high-intensity efforts lasting 1–30 seconds.

Strength

A 2003 meta-analysis of 22 trials found creatine supplementation increased maximum strength (1-rep max) by approximately 8% compared to placebo, versus 4% for placebo [Rawson & Volek 2003]. More recent systematic reviews have confirmed this effect across populations including trained athletes, untrained adults, and older adults.

The effect is most consistently seen in compound movements — squat, bench press, deadlift — and is smaller or absent for endurance performance lasting more than 3 minutes.

Power output

High-intensity interval outputs — sprint performance, cycling peak power, repeated jump height — are consistently improved by creatine in well-controlled trials. A meta-analysis by Branch (2003) found mean improvements of 7.5% in work performed during high-intensity intermittent exercise.

Lean body mass

Creatine supplementation reliably increases body mass by approximately 1–2 kg in the first 1–2 weeks, primarily reflecting water drawn into muscle cells alongside creatine. Longer-term lean mass gains — estimated at 1–2 kg of actual muscle over 4–12 weeks of resistance training — have been observed in multiple trials, though these gains are dependent on concurrent resistance training [Lanhers et al. 2017].

What research shows for cognitive performance

The brain also stores and uses creatine. A 2022 systematic review of 6 randomised trials found creatine supplementation improved short-term memory and intelligence/reasoning in healthy individuals, particularly under conditions of cognitive stress or sleep deprivation [Sandkühler & Bhanu Bhanu 2022; Forbes et al. 2022].

Effects on cognition in rested, well-nourished adults are smaller and less consistent than physical performance effects. The most robust findings are in populations with lower baseline creatine status: vegetarians, older adults, and sleep-deprived individuals.

How to spot underdosed products

Creatine is widely underdosed in multi-ingredient pre-workout formulas. The clinical dose is 3,000–5,000 mg per serving. Common underdosing patterns include:

• Proprietary blends: A "performance blend" listing creatine alongside several other ingredients may contain as little as 500–1,000 mg of creatine. Without individual ingredient disclosure, it is impossible to know.
• 1–2 g servings: Some products list creatine monohydrate at 1 g or 2 g per serving — below the minimum dose with evidence for muscle saturation.
• "Creatine complex" formulations: Products blending multiple creatine forms (monohydrate, HCl, ethyl ester) often total 2–3 g across all forms — below the clinical threshold for creatine monohydrate alone, and without evidence that the combination is superior.

The simplest check: if a product's label does not disclose the creatine monohydrate quantity clearly, or if the quantity is below 3,000 mg per serving, the dose is below what clinical trials have used to produce effects.

Timing and co-ingestion

Research on creatine timing is less conclusive than dose research. A 2013 study by Antonio & Ciccone suggested post-workout creatine may be marginally superior to pre-workout for lean mass and strength gains, but effect sizes were small and the finding has not been consistently replicated.

Creatine monohydrate can be taken at any time of day. Taking it with a meal containing carbohydrates and protein may slightly enhance uptake through insulin-mediated mechanisms, but the practical difference at maintenance doses is likely small [Steenge et al. 2000].

There is no established benefit to cycling creatine (taking breaks). Continuous daily supplementation at 3–5 g/day maintains muscle saturation without accumulation concerns.

Safety profile

Creatine monohydrate has an extensive safety record. The International Society of Sports Nutrition position stand (2017) concluded that creatine monohydrate is safe for healthy individuals at recommended doses across long-term use [Kreider et al. 2017].

• Kidney function: Multiple trials in healthy individuals show no adverse effect on kidney function markers. Individuals with pre-existing kidney disease should consult a physician before supplementing.
• Creatinine elevation: Creatine supplementation raises serum creatinine (a metabolic byproduct) without indicating kidney impairment — a known confound in clinical blood panels for creatine users.
• Hair loss: A widely cited 2009 study in rugby players found elevated DHT (a hormone associated with male-pattern hair loss) after creatine loading. This finding has not been replicated, and no controlled trial has demonstrated creatine-induced hair loss directly [van der Merwe et al. 2009].
• GI effects: Loading protocols (20 g/day) can cause transient GI discomfort in some individuals. Gradual dosing at 3–5 g/day avoids this.

What Proco's assessment is

Creatine monohydrate is among the best-evidenced sports supplements available. The dose (3–5 g/day), form (monohydrate), and primary outcomes (strength, power, lean mass) are well-established. The most common issues in commercial products are underdosing and unnecessary reformulation into proprietary blends that obscure the actual creatine content.

The Scanner checks the disclosed creatine monohydrate dose against the clinical threshold of 3,000 mg per serving — the minimum dose with consistent evidence for muscle saturation.

Related Proco pages

• Creatine and cognition: what the research shows
• VO₂ max: lab tests vs. wearable estimates
• HRV: what it measures and what affects it
• Ultra-processed foods: what research has measured
• How to read a clinical trial

Sources